1 - 25 of
61
results
for author:"Green A.R."
in Literature Citations
| JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Dawson M.A., Bannister A.J., Gottgens B., Foster S.D., Bartke T., Green A.R., Kouzarides T. Nature 461:819-822(2009) · Mapped (8) |
| ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling. Wood A.D., Chen E., Donaldson I.J., Hattangadi S., Burke K.A., Dawson M.A., Miranda-Saavedra D., Lodish H.F., Green A.R., Gottgens B. Blood 114:1820-1830(2009) · Mapped (23) |
| The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR. Green A.R., Young P., Krivinskas S., Rakha E.A., Claire Paish E., Powe D.G., Ellis I.O. Histopathology 54:419-427(2009) · Mapped (69) |
| SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases. Elliott J., Suessmuth Y., Scott L.M., Nahlik K., McMullin M.F., Constantinescu S.N., Green A.R., Johnston J.A. Haematologica 94:576-580(2009) · Mapped (9) |
| Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders. Fourouclas N., Li J., Gilby D.C., Campbell P.J., Beer P.A., Boyd E.M., Goodeve A.C., Bareford D., Harrison C.N., Reilly J.T. et al. Haematologica 93:1635-1644(2008) · Mapped (5) |
| Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Bercovich D., Ganmore I., Scott L.M., Wainreb G., Birger Y., Elimelech A., Shochat C., Cazzaniga G., Biondi A., Basso G. et al. Lancet 372:1484-1492(2008) · Mapped (6) |
| Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Shaaban A.M., Green A.R., Karthik S., Alizadeh Y., Hughes T.A., Harkins L., Ellis I.O., Robertson J.F., Paish E.C., Saunders P.T. et al. Clin. Cancer Res. 14:5228-5235(2008) · Mapped (6) |
| MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort. Beer P.A., Campbell P.J., Scott L.M., Bench A.J., Erber W.N., Bareford D., Wilkins B.S., Reilly J.T., Hasselbalch H.C., Bowman R. et al. Blood 112:141-149(2008) · Mapped (3) |
| Expression of BRCA1 protein in breast cancer and its prognostic significance. Rakha E.A., El-Sheikh S.E., Kandil M.A., El-Sayed M.E., Green A.R., Ellis I.O. Hum. Pathol. 39:857-865(2008) · Mapped (33) |
| Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast. Green A.R., Krivinskas S., Young P., Rakha E.A., Paish E.C., Powe D.G., Ellis I.O. Breast Cancer Res. Treat. 113:59-66(2009) · UniProtKB (1) |
| The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Percy M.J., Scott L.M., Erber W.N., Harrison C.N., Reilly J.T., Jones F.G., Green A.R., McMullin M.F. Haematologica 92:1607-1614(2007) · Mapped (6) |
| The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo. Wienke D., Davies G.C., Johnson D.A., Sturge J., Lambros M.B., Savage K., Elsheikh S.E., Green A.R., Ellis I.O., Robertson D. et al. Cancer Res. 67:10230-10240(2007) · Mapped (3) |
| Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Pimanda J.E., Ottersbach K., Knezevic K., Kinston S., Chan W.Y., Wilson N.K., Landry J.R., Wood A.D., Kolb-Kokocinski A., Green A.R. et al. Proc. Natl. Acad. Sci. U.S.A. 104:17692-17697(2007) · Mapped (18) |
| CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome. Elsheikh S., Green A.R., Aleskandarany M.A., Grainge M., Paish C.E., Lambros M.B., Reis-Filho J.S., Ellis I.O. Breast Cancer Res. Treat. 109:325-335(2008) · Mapped (6) |
| FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Elbauomy Elsheikh S., Green A.R., Lambros M.B., Turner N.C., Grainge M.J., Powe D., Ellis I.O., Reis-Filho J.S. Breast Cancer Res. 9:R23-R23(2007) · Mapped (11) |
| Patterns of somatic mutation in human cancer genomes. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C. et al. Nature 446:153-158(2007) · UniProtKB (453) |
| Temporal regulation of Cre-recombinase activity in Scl-positive neurons of the central nervous system. Bradley C.K., Takano E.A., Gothert J.R., Gottgens B., Green A.R., Begley C.G., van Eekelen J.A. Genesis 45:145-151(2007) · Mapped (3) |
| JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. Scott L.M., Tong W., Levine R.L., Scott M.A., Beer P.A., Stratton M.R., Futreal P.A., Erber W.N., McMullin M.F., Harrison C.N. et al. N. Engl. J. Med. 356:459-468(2007) · UniProtKB (1) · Mapped (5) |
| The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity. Pimanda J.E., Donaldson I.J., de Bruijn M.F., Kinston S., Knezevic K., Huckle L., Piltz S., Landry J.R., Green A.R., Tannahill D. et al. Proc. Natl. Acad. Sci. U.S.A. 104:840-845(2007) · Mapped (6) |
| DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH. Zhao R., Oxley D., Smith T.S., Follows G.A., Green A.R., Alexander D.R. PLoS Biol. 5:e1-e1(2007) · Mapped (13) |
| The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish. Patterson L.J., Gering M., Eckfeldt C.E., Green A.R., Verfaillie C.M., Ekker S.C., Patient R.K. |
| The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/-phenotype. Chan W.Y., Follows G.A., Lacaud G., Pimanda J.E., Landry J.R., Kinston S., Knezevic K., Piltz S., Donaldson I.J., Gambardella L. et al. Blood 109:1908-1916(2007) · Mapped (1) |
| An acquired translocation in JAK2 Val617Phe-negative essential thrombocythemia associated with autosomal spread of X-inactivation. Vassiliou G.S., Campbell P.J., Li J., Roberts I., Swanton S., Huntly B.J., Fourouclas N., Baxter E.J., Munro L.R., Culligan D.A. et al. Haematologica 91:1100-1104(2006) · Mapped (6) |
| Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation. Campbell P.J., Baxter E.J., Beer P.A., Scott L.M., Bench A.J., Huntly B.J., Erber W.N., Kusec R., Larsen T.S., Giraudier S. et al. Blood 108:3548-3555(2006) · Mapped (6) |
| Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. Scott L.M., Scott M.A., Campbell P.J., Green A.R. Blood 108:2435-2437(2006) · Mapped (6) |
